Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 33841-33842 [2013-13284]
Download as PDF
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License Applicants
The Commission gives notice that the
following applicants have filed an
application for an Ocean Transportation
Intermediary (OTI) license as a NonVessel-Operating Common Carrier
(NVO) and/or Ocean Freight Forwarder
(OFF) pursuant to section 19 of the
Shipping Act of 1984 (46 U.S.C. 40101).
Notice is also given of the filing of
applications to amend an existing OTI
license or the Qualifying Individual (QI)
for a licensee.
Interested persons may contact the
Office of Ocean Transportation
Intermediaries, Federal Maritime
Commission, Washington, DC 20573, by
telephone at (202) 523–5843 or by email
at OTI@fmc.gov.
CFR Rinkens, LLC dba Rinkens
International dba CFR Line (NVO),
15501 Texaco Avenue, Paramount,
CA 90723, Officers: Maximiliaan
Hoes, Manager (QI), Michele
Blackmore, Vice President,
Application Type: Add NVO Service.
Javelin Logistics Corporation (NVO &
OFF), 7447A Morton Avenue,
Newark, CA 94560, Officers: Susan M.
Foster, International Services (QI),
Malcolm Winspear, President,
Application Type: QI Change.
Sig Global, Inc. (NVO & OFF), 16012 S.
Western Avenue, Suite 300, Gardena,
CA 90247, Officers: James J. Oh,
President (QI), Chung Kwon Kim,
Secretary, Application Type: New
NVO & OFF License.
Super You Global (NVO & OFF), 391
Curtner Avenue, Suite 1, Palo Alto,
CA 94306, Officers: Hu Wang, CEO
(QI), Xin You, President, Application
Type: New NVO & OFF License.
Windstream International Inc. (NVO &
OFF), 2001 Santa Anita Avenue, Suite
203A, South El Monte, CA 91733,
Officer: Jeff C. Chang, CEO (QI),
Application Type: New NVO & OFF
License.
By the Commission.
Dated: May 31, 2013.
Rachel E. Dickon,
Assistant Secretary.
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License Revocations
The Commission gives notice that the
following Ocean Transportation
Intermediary licenses have been
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
revoked pursuant to section 19 of the
Shipping Act of 1984 (46 U.S.C. 40101)
effective on the date shown.
License No.: 3642F.
Name: Honeybee International
Forwarding.
Address: 2301 S. Tubeway Avenue,
Commerce, CA 90040.
Date Revoked: May 16, 2013.
Reason: Voluntary Surrender of
License.
License No.: 015890NF.
Name: OEC Freight Chicago, Inc.
Address: 501 Frontier Way,
Bensenville, IL 60106.
Date Revoked: May 6, 2013.
Reason: Voluntary Surrender of
License.
License No.: 021796NF.
Name: Keith Phillips Transportation,
LLC.
Address: 124 Garden Gate Drive,
Ponte Vedra Beach, FL 32082.
Date Revoked: May 15, 2013.
Reason: Voluntary Surrender of
License.
License No.: 021952NF.
Name: Streamline Trade Management
Inc. dba Teamwork Logistic.
Address: 177–25 Rockaway Blvd.
Suite 213, Jamaica, NY 11434.
Date Revoked: May 9, 2013.
Reason: Voluntary Surrender of
License.
License No.: 023793NF.
Name: Interlink Cargo Logistics, LLC.
Address: 76 Loy Avenue, Riverdale,
NJ 07457.
Date Revoked: May 14, 2013.
Reason: Voluntary Surrender of
License.
Consistent with its statutory mandate,
the Federal Open Market Committee
seeks monetary and financial conditions
that will foster maximum employment
and price stability. In particular, the
Committee seeks conditions in reserve
markets consistent with federal funds
trading in a range from 0 to 1⁄4 percent.
The Committee directs the Desk to
undertake open market operations as
necessary to maintain such conditions.
The Desk is directed to continue
purchasing longer-term Treasury
securities at a pace of about $45 billion
per month and to continue purchasing
agency mortgage-backed securities at a
pace of about $40 billion per month.
The Committee also directs the Desk to
engage in dollar roll and coupon swap
transactions as necessary to facilitate
settlement of the Federal Reserve’s
agency mortgage-backed securities
transactions. The Committee directs the
Desk to maintain its policy of rolling
over maturing Treasury securities into
new issues and its policy of reinvesting
principal payments on all agency debt
and agency mortgage-backed securities
in agency mortgage-backed securities.
The System Open Market Account
Manager and the Secretary will keep the
Committee informed of ongoing
developments regarding the System’s
balance sheet that could affect the
attainment over time of the Committee’s
objectives of maximum employment
and price stability.
James A. Nussbaumer,
Deputy Director, Bureau of Certification and
Licensing.
BILLING CODE 6210–01–P
[FR Doc. 2013–13327 Filed 6–4–13; 8:45 am]
By order of the Federal Open Market
Committee, May 23, 2013.
William B. English,
Secretary, Federal Open Market Committee.
[FR Doc. 2013–13271 Filed 6–4–13; 8:45 am]
FEDERAL RESERVE SYSTEM
BILLING CODE 6730–01–P
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
FEDERAL RESERVE SYSTEM
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Federal Open Market Committee;
Domestic Policy Directive of April 30–
May 1, 2013
In accordance with Section 271.25 of
its rules regarding availability of
information (12 CFR part 271), there is
set forth below the domestic policy
directive issued by the Federal Open
Market Committee at its meeting held
on April 30–May 1, 2013.1
[FR Doc. 2013–13325 Filed 6–4–13; 8:45 am]
33841
1 Copies of the Minutes of the Federal Open
Market Committee at its meeting held on April 30–
May 1, 2013, which includes the domestic policy
directive issued at the meeting, are available upon
request to the Board of Governors of the Federal
Reserve System, Washington, DC 20551. The
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
minutes are published in the Federal Reserve
Bulletin and in the Board’s Annual Report.
E:\FR\FM\05JNN1.SGM
05JNN1
33842
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 1, 2013.
A. Federal Reserve Bank of Boston
(Richard Walker, Community Affairs
Officer) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204:
1. Hometown Community Bancorp,
MHC, Oxford, Massachusetts; to acquire
100 percent of the voting shares of
Hometown Community Bancorp, Inc.,
Oxford, Massachusetts, which will
acquire Hometown Bank, A Cooperative
Bank, Webster, Massachusetts.
In addition, Hometown Community
Bancorp, Inc., Oxford, Massachusetts,
also has applied to become a bank
holding company, by acquiring
Hometown Bank, A Cooperative Bank,
Webster, Massachusetts.
Board of Governors of the Federal Reserve
System, May 31, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013–13284 Filed 6–4–13; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Determination and Declaration
Regarding Emergency Use of In Vitro
Diagnostics for Detection of Middle
East Respiratory Syndrome
Coronavirus (MERS-CoV)
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
SUMMARY: The Secretary of Health and
Human Services (HHS) is issuing this
notice pursuant to section 564 of the
Federal Food, Drug, and Cosmetic
(FD&C) Act, 21 U.S.C. 360bbb–3. On
May 29, 2013, the Secretary determined
that there is a significant potential for a
public health emergency that has a
significant potential to affect national
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
security or the health and security of
United States citizens living abroad and
that involves Middle East respiratory
syndrome coronavirus (MERS-CoV).
On the basis of this determination,
she also declared that circumstances
exist justifying the authorization of
emergency use of in vitro diagnostics for
detection of Middle East respiratory
syndrome coronavirus (MERS-CoV)
pursuant to section 564 of the FD&C
Act, subject to the terms of any
authorization issued under that section.
DATES: The determination and
declaration are effective May 29, 2013.
FOR FURTHER INFORMATION CONTACT:
Nicole Lurie, M.D., MSPH, Assistant
Secretary for Preparedness and
Response, Office of the Secretary,
Department of Health and Human
Services, 200 Independence Avenue
SW., Washington, DC 20201, Telephone
(202) 205–2882 (this is not a toll free
number).
SUPPLEMENTARY INFORMATION:
I. Background
Under Section 564 of the FD&C Act,
the Commissioner of the Food and Drug
Administration (FDA), acting under
delegated authority from the Secretary
of HHS, may issue an Emergency Use
Authorization (EUA) authorizing (1) the
emergency use of an unapproved drug,
an unapproved or uncleared device, or
an unlicensed biological product; or (2)
an unapproved use of an approved drug,
approved or cleared device, or licensed
biological product. Before an EUA may
be issued, the Secretary of HHS must
declare that circumstances exist
justifying the authorization based on
one of four determinations: (1) A
determination by the Secretary of
Homeland Security that there is a
domestic emergency, or a significant
potential for a domestic emergency,
involving a heightened risk of attack
with a, chemical, biological,
radiological, or nuclear (‘‘CBRN’’) agent
or agents; (2) the identification of a
material threat by the Secretary of
Homeland Security pursuant to section
319F–2 of the Public Health Service
(PHS) Act 1 sufficient to affect national
security or the health and security of
United States citizens living abroad; (3)
a determination by the Secretary of
Defense that there is a military
emergency, or a significant potential for
a military emergency, involving a
heightened risk to United States military
forces of attack with a CBRN agent or
agents; or (4) a determination by the
Secretary that there is a public health
emergency, or a significant potential for
1 42
PO 00000
U.S.C. 247d–6b
Frm 00045
Fmt 4703
Sfmt 4703
a public health emergency, that affects,
or has a significant potential to affect,
national security or the health and
security of United States citizens living
abroad, and that involves a CBRN agent
or agents, or a disease or condition that
may be attributable to such agent or
agents.2
Based on any of these four
determinations, the Secretary of HHS
may then declare that circumstances
exist that justify the EUA, at which
point the FDA Commissioner may issue
an EUA if the criteria for issuance of an
authorization under section 564 of the
FD&C Act are met.
The Centers for Disease Control and
Prevention (CDC), HHS, requested that
the FDA, HHS, issue an EUA for in vitro
diagnostics for detection of Middle East
respiratory syndrome coronavirus
(MERS-CoV) to allow the Department to
take preparedness measures based on
information currently available about
the Middle East respiratory syndrome
coronavirus (MERS-CoV). The
determination of a significant potential
for a public health emergency, and the
declaration that circumstances exist
justifying emergency use of in vitro
diagnostics for detection of Middle East
respiratory syndrome coronavirus
(MERS-CoV) by the Secretary of HHS, as
described below, enable the FDA
Commissioner to issue an EUA for
certain in vitro diagnostics for
emergency use under section 564 of the
FD&C Act.
II. Determination by the Secretary of
Health and Human Services
On May 29, 2013, pursuant to section
564 of the FD&C Act, I determined that
there is a significant potential for a
public health emergency that has a
significant potential to affect national
security or the health and security of
United States citizens living abroad and
that involves Middle East respiratory
syndrome coronavirus (MERS-CoV).
III. Declaration of the Secretary of
Health and Human Services
Also on May 29, 2013, on the basis of
my determination of a significant
potential for a public health emergency
that has a significant potential to affect
national security or the health and
security of United States citizens living
2 As amended by the Pandemic and All-Hazards
Preparedness Reauthorization Act, Public Law 113–
5, the Secretary may make determination of a public
health emergency, or a significant potential for a
public health emergency, under section 564 of the
FD&C Act. The Secretary is no longer required to
make a determination of a public health emergency
in accordance with section 319 of the PHS Act, 42
U.S.C. 247d to support a determination or
declaration made under section 564 of the FD&C
Act.
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 78, Number 108 (Wednesday, June 5, 2013)]
[Notices]
[Pages 33841-33842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13284]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the
[[Page 33842]]
Board, are available for immediate inspection at the Federal Reserve
Bank indicated. The applications will also be available for inspection
at the offices of the Board of Governors. Interested persons may
express their views in writing on the standards enumerated in the BHC
Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition
of a nonbanking company, the review also includes whether the
acquisition of the nonbanking company complies with the standards in
section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than July 1, 2013.
A. Federal Reserve Bank of Boston (Richard Walker, Community
Affairs Officer) 600 Atlantic Avenue, Boston, Massachusetts 02210-2204:
1. Hometown Community Bancorp, MHC, Oxford, Massachusetts; to
acquire 100 percent of the voting shares of Hometown Community Bancorp,
Inc., Oxford, Massachusetts, which will acquire Hometown Bank, A
Cooperative Bank, Webster, Massachusetts.
In addition, Hometown Community Bancorp, Inc., Oxford,
Massachusetts, also has applied to become a bank holding company, by
acquiring Hometown Bank, A Cooperative Bank, Webster, Massachusetts.
Board of Governors of the Federal Reserve System, May 31, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013-13284 Filed 6-4-13; 8:45 am]
BILLING CODE 6210-01-P